Drug Repurposing Call to Treat Chronic Respiratory Infection
Funds UK-led consortia repurposing drugs for bronchiectasis and cystic fibrosis.
About
LifeArc committed £10 million to fund up to five consortia programmes, with a maximum award of £2.5 million each, as part of its Translational Challenge in Chronic Respiratory Infection. Academic, government and SME organisations could apply, with large companies allowed only as co-investigators (LifeArc wouldn't cover their costs); the lead organisation had to be UK-based, though participants cou…
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.